157 related articles for article (PubMed ID: 36833798)
1. Association between Dietary Fatty Acid Intake and Liver Steatosis and Fibrosis in a Sample of Mexican-Origin Hispanic Adults with Overweight or Obesity.
Lopez-Pentecost M; Hallmark B; Thomson CA; Chilton F; Garcia DO
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833798
[TBL] [Abstract][Full Text] [Related]
2. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity.
Lopez-Pentecost M; Tamez M; Mattei J; Jacobs ET; Thomson CA; Garcia DO
Nutrients; 2023 Dec; 15(23):. PubMed ID: 38068856
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.
Abeysekera KWM; Fernandes GS; Hammerton G; Portal AJ; Gordon FH; Heron J; Hickman M
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):295-305. PubMed ID: 31954687
[TBL] [Abstract][Full Text] [Related]
4. Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S.
Heredia NI; Zhang X; Balakrishnan M; Hwang JP; Thrift AP
Ethn Health; 2023 Feb; 28(2):299-312. PubMed ID: 35067116
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Hepatic Steatosis and Fibrosis in the United States.
Choi YS; Beltran TA; Calder SA; Padilla CR; Berry-Cabán CS; Salyer KR
Metab Syndr Relat Disord; 2022 Apr; 20(3):141-147. PubMed ID: 34962146
[No Abstract] [Full Text] [Related]
6. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.
Abeysekera KWM; Orr JG; Gordon FH; Howe LD; Hamilton-Shield J; Heron J; Hickman M
BMC Gastroenterol; 2022 Jun; 22(1):323. PubMed ID: 35773644
[TBL] [Abstract][Full Text] [Related]
7. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
[TBL] [Abstract][Full Text] [Related]
8. Increased Intake of Both Caffeine and Non-Caffeine Coffee Components Is Associated with Reduced NAFLD Severity in Subjects with Type 2 Diabetes.
Coelho M; Patarrão RS; Sousa-Lima I; Ribeiro RT; Meneses MJ; Andrade R; Mendes VM; Manadas B; Raposo JF; Macedo MP; Jones JG
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615664
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV.
de Almeida CF; da Silva PS; Cardoso CSA; Moreira NG; Antunes JC; de Andrade MM; Silva J; Araujo MC; Peres WAF; do Brasil PEAA; Moreira RI; Cardoso SW; Veloso VG; Grinsztejn B; de Brito PD; Perazzo H
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684463
[TBL] [Abstract][Full Text] [Related]
10. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
Lin CL; Tai CM; Huang JF; Liu CJ; Chen HF; Cheng PN; Chen CY; Peng CY; Wang CC; Weng SH; Tseng TC; Kao JH
J Gastroenterol Hepatol; 2022 Oct; 37(10):1901-1910. PubMed ID: 35790343
[TBL] [Abstract][Full Text] [Related]
11. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
12. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016.
Kim D; Kim W; Adejumo AC; Cholankeril G; Tighe SP; Wong RJ; Gonzalez SA; Harrison SA; Younossi ZM; Ahmed A
Hepatol Int; 2019 Mar; 13(2):205-213. PubMed ID: 30694445
[TBL] [Abstract][Full Text] [Related]
13. Assessing Interactions between
Morrill KE; Bland VL; Klimentidis YC; Hingle MD; Thomson CA; Garcia DO
Int J Environ Res Public Health; 2021 Jul; 18(13):. PubMed ID: 34280991
[TBL] [Abstract][Full Text] [Related]
14. Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease.
Di Ciaula A; Shanmugam H; Ribeiro R; Pina A; Andrade R; Bonfrate L; Raposo JF; Macedo MP; Portincasa P
Eur J Intern Med; 2023 Jan; 107():52-59. PubMed ID: 36344354
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study.
Martínez-Ortega AJ; Piñar Gutiérrez A; Lara-Romero C; Remón Ruiz PJ; Ampuero-Herrojo J; de Lara-Rodríguez I; Romero-Gómez M; García Luna PP; Soto-Moreno A
Nutr Hosp; 2022 Oct; 39(5):1012-1018. PubMed ID: 36134588
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.
Li MR; Li JZ; Li JY; Wang CC; Yuan RK; Ye LH; Liu YY; Liang XJ; Zhang HC; Liu ZQ; Zeng DY; Zhang XD; Wang DH; Li JQ; Li TY; Yang L; Cao Y; Pan Y; Lin XG; Pan CQ; Dai EH; Dong ZY
Obes Facts; 2023; 16(5):427-434. PubMed ID: 37231905
[TBL] [Abstract][Full Text] [Related]
17. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis.
Lomonaco R; Ortiz-Lopez C; Orsak B; Finch J; Webb A; Bril F; Louden C; Tio F; Cusi K
Hepatology; 2011 Sep; 54(3):837-45. PubMed ID: 21674556
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
19. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
[TBL] [Abstract][Full Text] [Related]
20. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
